Wegovy Results After Month 6: Realistic Weight Loss Expectations

Introduction

Six months on Wegovy® is where the bulk of the heavy lifting happens. By week 26 you have been on the full 2.4 mg dose for about 10 weeks, the appetite suppression is fully expressed, and the cumulative weight loss has crossed into territory that meaningfully changes clothes and labs.

Realistic month 6 results are 11 to 14 percent of starting body weight, which works out to about 24 to 31 pounds for a 220 pound start. That tracks STEP 1 (Wilding et al. 2021 NEJM) closely. The trial reported 12.4 percent mean loss at week 28.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

How Much Weight Should You Lose by Month 6 on Wegovy?

Typical month 6 weight loss on Wegovy is 11 to 14 percent of starting body weight. For a 220 pound starting weight that means 24 to 31 pounds gone by week 26. Some adherent patients reach 15 to 17 percent at month 6 if they responded strongly to the dose escalation.

Quick Answer: Month 6 weight loss on Wegovy averages 11 to 14 percent of starting body weight

STEP 1 (Wilding et al. 2021 NEJM) reported 12.4 percent mean body weight reduction at week 28 in 1,961 adults on semaglutide 2.4 mg. The week 26 number by interpolation is about 11.5 to 12 percent.

Real-world adherent users tend to track 1 to 2 percentage points below trial averages. A 2024 Truveta cohort of 16,229 adults on semaglutide showed mean week 26 loss of about 10.2 percent among adherent patients. Population averages including dropouts were lower at 5 to 6 percent.

For very high BMI starting weights (BMI over 40), month 6 results in absolute pounds can be 35 to 50 pounds. The percentage stays similar to the trial average; the absolute number scales with starting weight.

Why Is Month 6 a Major Decision Point?

Month 6 is a major decision point because the response curve has flattened enough to predict the 12 month outcome, and the lab work captures the metabolic benefits beyond weight alone. Most clinicians review labs and dose at month 6.

A 2023 analysis in Diabetes Obesity Metabolism by Wilding and colleagues showed week 28 response strongly predicts week 68 outcomes. Patients at 10 percent or more at week 28 averaged 16 to 18 percent at week 68. Patients below 8 percent at week 28 rarely exceeded 12 percent at the trial endpoint.

The decision to stay the course, switch to tirzepatide, or add adjunct interventions usually happens at month 6 based on response, side effects, and adherence patterns. Some patients also discuss dose reduction at this point if they have hit a target weight.

Labs at month 6 typically include A1c, lipid panel, kidney function, liver enzymes, and sometimes vitamin B12 because semaglutide can blunt B12 absorption over time. TrimRx’s personalized treatment plan schedules the 6 month review automatically.

What Metabolic Improvements Show up at Month 6?

Metabolic improvements at month 6 are often more clinically meaningful than the weight loss itself. A1c usually drops 0.8 to 1.5 percentage points in non-diabetic patients and 1.5 to 2.0 in diabetic patients. Blood pressure falls 5 to 8 mmHg systolic.

SELECT (Lincoff et al. 2023 NEJM), the cardiovascular outcomes trial in 17,604 non-diabetic adults with obesity and CVD, showed 20 percent reduction in major adverse cardiovascular events on 2.4 mg semaglutide over a mean 39 months. Most of the surrogate metabolic improvements stabilized by month 6.

Triglycerides typically drop 20 to 30 percent and HDL rises modestly. LDL changes are smaller and less consistent. Inflammatory markers like hs-CRP often improve by 30 to 40 percent in patients with elevated baseline values.

FLOW (Perkovic et al. 2024 NEJM), enrolling 3,533 patients with type 2 diabetes and CKD on 1 mg semaglutide, showed 24 percent reduction in kidney failure and CV death over 3.4 years. Most kidney function improvements were visible by month 6.

What Dose Are Most Patients on at Month 6?

Most patients are on the 2.4 mg maintenance dose by month 6. The escalation finishes at week 17 with the move to 2.4 mg, and patients stay there indefinitely unless side effects force a step down.

A subset of patients can’t tolerate 2.4 mg and remain at 1.7 mg long-term. STEP 1 had about 17 percent of patients on lower-than-target dose due to side effects. Weight loss at the lower dose is slightly less, with 1.7 mg producing about 12 to 13 percent at week 68 versus 14.9 percent on 2.4 mg.

The 2.4 mg dose triggers a brief wave of side effects in many patients, lasting 7 to 14 days after the first injection at this dose. Most settle by week 20 to 22. By month 6 the side effect picture is usually stable.

Why Do Plateaus Happen Around Month 5 to 6?

Plateaus around month 5 to 6 are biological, driven by adaptive thermogenesis lowering resting metabolic rate to match the new lower body weight. The scale stops moving in either direction for weeks at a time, often before the medication reaches peak effect.

Fothergill 2016 (Obesity journal) tracked Biggest Loser contestants and found resting metabolic rate dropped about 500 calories per day below predicted after major weight loss. The same compensatory pattern shows up in GLP-1 trials, just blunted by the sustained appetite suppression.

Gastric emptying also partially normalizes. Halawi 2017 (Lancet Gastroenterol Hepatol) showed the gastric delay from liraglutide attenuates over time. Patients can eat slightly more volume at month 6 than at month 1 on the same dose, even though the satiety signal remains active.

Most plateaus break within 4 to 6 weeks if protein, resistance training, and sleep are on point. A small minority of patients need a brief deficit recalibration or accept the new weight as a maintenance target.

Key Takeaway: The full 2.4 mg dose runs from week 17 onward as maintenance

How Does Month 6 Wegovy Compare to Month 6 Ozempic®?

Wegovy at month 6 outperforms Ozempic at month 6 by about 2 to 3 percentage points because Wegovy reaches the higher 2.4 mg dose while Ozempic tops out at 2 mg. Both produce strong results; Wegovy just has a higher ceiling.

Typical Ozempic month 6 loss is 9 to 12 percent versus Wegovy’s 11 to 14 percent. The gap is small but consistent across trial datasets and real-world cohorts.

The practical decision between them comes down to indication, insurance, and supply rather than efficacy. Wegovy is approved for obesity; Ozempic is approved for type 2 diabetes. Patients without diabetes who want maximum weight loss are usually placed on Wegovy.

TrimRx’s compounded semaglutide can be titrated to the Wegovy-equivalent 2.4 mg dose, producing comparable month 6 results without supply or insurance constraints.

What Side Effects Persist at Month 6?

By month 6 acute GI side effects are usually gone for the majority of patients. The Novo Nordisk safety pooling showed nausea incidence under 5 percent at month 6 on stable dosing. Vomiting and diarrhea are similarly uncommon.

Constipation persists for many patients because it is mechanism-driven by sustained gastric and intestinal slowing. Magnesium citrate, fiber, and hydration remain useful. About 24 percent of STEP 1 participants reported constipation at some point.

Hair shedding usually peaks around month 4 to 5 and starts resolving by month 6. About 3 percent of STEP 1 patients reported hair loss. It is telogen effluvium from rapid weight loss, not direct drug toxicity, and almost always resolves within 6 to 12 months.

Gallbladder disease risk continues through month 6. The He 2022 meta-analysis in JAMA Internal Medicine showed a 37 percent increased risk on GLP-1 agonists, with most cases appearing in the first 6 months. Right upper quadrant pain warrants a clinician call.

What Should You Focus on Between Month 6 and 12?

Months 6 to 12 are about consolidation and habit lock-in. The remaining weight loss runway is real but slower, so the focus shifts to lean mass preservation, sleep, and habits that will hold once the loss phase ends.

Resistance training 3 times weekly with progressive load is the single best lever for lean mass. Protein at 0.7 to 1 g per pound of goal body weight is the second. The combination preserves the metabolic rate that adaptive thermogenesis tries to erode.

Sleep affects body composition meaningfully. Nedeltcheva 2010 in Annals of Internal Medicine showed sleep restriction shifted weight loss from fat to lean mass by 55 percent under matched calorie deficits. Aim for 7 to 8 hours.

The plateau most patients hit between month 9 and 12 is the real test of the protocol. Patients who lean into resistance work, sleep, and consistent protein usually push another 2 to 4 percent loss in that window. The TrimRx free assessment quiz is the entry point for personalized protocols.

Bottom line: Plateau patterns begin to appear around month 5 to 6 for some patients

FAQ

Is 25 Pounds in 6 Months on Wegovy Good?

Yes. Twenty-five pounds at month 6 for a 220 pound starting weight is right in the typical 11 to 14 percent range. That matches STEP 1 trial data for adherent patients on the standard escalation.

Why Am I Plateauing at Month 6 on Wegovy?

Plateaus at month 6 are common because adaptive thermogenesis lowers resting metabolic rate and gastric emptying partially normalizes. Most plateaus break within 4 to 6 weeks with protein, resistance training, and a small calorie audit.

Should I Switch to Mounjaro® or Zepbound® at Month 6?

A switch makes sense if response has stalled below 8 percent total or if A1c hasn’t improved enough. SURMOUNT-1 showed tirzepatide produces 20.9 percent loss at week 72 versus 14.9 percent for semaglutide.

Can I Stop Wegovy After 6 Months If I’ve Hit My Goal?

Stopping at 6 months usually leads to weight regain. STEP 4 (Rubino et al. 2021 JAMA) showed patients regained about two-thirds of lost weight within 12 months of stopping. Long-term maintenance is the standard recommendation.

What Dose Should I Be on at 6 Months?

Most patients are on the 2.4 mg maintenance dose by month 6. Some stay at 1.7 mg long-term due to side effects, which produces slightly less weight loss but still strong outcomes.

Does Wegovy Still Work After 6 Months?

Yes. Weight loss continues through month 12 for most adherent patients, just at a slower pace. STEP 1 showed continued loss to 14.9 percent by week 68, with the curve only flattening around month 14 to 18.

How Accurate Are STEP 1 Trial Numbers for Predicting My Results?

STEP 1 mean numbers are reasonable predictors for adherent patients on the standard escalation. Variance is high though, with the trial standard deviation wide enough to span 5 to 25 percent loss at week 68.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.